Intuitive Surgical, Inc. $ISRG Shares Bought by AMF Tjanstepension AB

AMF Tjanstepension AB increased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 8.6% during the 4th quarter, Holdings Channel reports. The fund owned 212,396 shares of the medical equipment provider’s stock after purchasing an additional 16,758 shares during the quarter. AMF Tjanstepension AB’s holdings in Intuitive Surgical were worth $120,293,000 as of its most recent SEC filing.

Other hedge funds have also modified their holdings of the company. Newbridge Financial Services Group Inc. raised its stake in shares of Intuitive Surgical by 300.0% in the fourth quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 33 shares in the last quarter. Holos Integrated Wealth LLC acquired a new stake in shares of Intuitive Surgical in the fourth quarter valued at $25,000. Olistico Wealth LLC acquired a new stake in shares of Intuitive Surgical in the fourth quarter valued at $28,000. Laurel Wealth Advisors LLC acquired a new stake in shares of Intuitive Surgical in the fourth quarter valued at $31,000. Finally, Turning Point Benefit Group Inc. raised its stake in shares of Intuitive Surgical by 833.3% in the fourth quarter. Turning Point Benefit Group Inc. now owns 56 shares of the medical equipment provider’s stock valued at $32,000 after acquiring an additional 50 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several analysts have recently issued reports on the company. TD Cowen reduced their price objective on Intuitive Surgical from $660.00 to $585.00 and set a “buy” rating on the stock in a research note on Wednesday, April 22nd. Zacks Research cut Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research note on Monday, March 30th. Truist Financial reduced their price objective on Intuitive Surgical from $650.00 to $580.00 and set a “buy” rating on the stock in a research note on Wednesday, April 15th. HSBC reduced their price objective on Intuitive Surgical from $653.00 to $604.00 and set a “buy” rating on the stock in a research note on Wednesday, April 22nd. Finally, Barclays set a $651.00 price target on Intuitive Surgical and gave the company an “overweight” rating in a research note on Thursday, April 23rd. Nineteen analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $579.33.

Insider Buying and Selling

In other Intuitive Surgical news, EVP Gary Loeb sold 400 shares of the firm’s stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $446.95, for a total transaction of $178,780.00. Following the transaction, the executive vice president owned 6,120 shares of the company’s stock, valued at approximately $2,735,334. This trade represents a 6.13% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Mark Brosius sold 645 shares of the firm’s stock in a transaction dated Monday, March 9th. The stock was sold at an average price of $485.01, for a total value of $312,831.45. Following the transaction, the senior vice president directly owned 1,613 shares in the company, valued at approximately $782,321.13. The trade was a 28.57% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 5,647 shares of company stock valued at $2,760,359 over the last 90 days. 0.60% of the stock is currently owned by corporate insiders.

Intuitive Surgical Price Performance

Intuitive Surgical stock opened at $439.92 on Tuesday. Intuitive Surgical, Inc. has a 1-year low of $417.74 and a 1-year high of $603.88. The stock has a market cap of $155.80 billion, a PE ratio of 53.32, a P/E/G ratio of 3.36 and a beta of 1.51. The stock’s fifty day moving average is $462.50 and its two-hundred day moving average is $513.03.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share for the quarter, beating analysts’ consensus estimates of $2.08 by $0.42. Intuitive Surgical had a return on equity of 15.98% and a net margin of 28.15%.The company had revenue of $2.77 billion for the quarter, compared to analysts’ expectations of $2.62 billion. During the same period last year, the firm earned $1.81 earnings per share. Intuitive Surgical’s quarterly revenue was up 23.0% on a year-over-year basis. On average, research analysts expect that Intuitive Surgical, Inc. will post 8.57 earnings per share for the current fiscal year.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.